Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001104659-20-075234

Options or other derivatives

  • Chief Executive Officer acquired 221,241 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Erlander Mark Chief Executive Officer 2020-06-17 Grant or award · Stock Options +221,241 380,200 D: show line 1 in the form
Loading xslF345X03/a4.xml…